Aberg JA. Aging, inflammation, and HIV infection. Top Antivir Med. 2012;20:101-105.
Belzile JP, Abrahamyan LG, Gérard FC, et al. Formation of mobile chromatin-associated nuclear foci containing HIV-1 Vpr and VPRBP is critical for the induction of G2 cell cycle arrest. PLoS Pathog. 2010;6:e1001080.
Bernard NF, Chernoff DN, Tsoukas CM. Effect of splenectomy on T-cell subsets and plasma HIV viral titers in HIV-infected patients. J Hum Virol. 1998;1:338-345.
Blanco J, Barretina J, Clotet B, et al. R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism. J Leukoc Biol. 2004;76:804-811.
Crampin AC, Mwaungulu FD, Ambrose LR, et al. Normal range of CD4 cell counts and temporal changes in two HIV negative malawian populations. Open AIDS J. 2011;5:74-79.
Doitsh G, Galloway NLK, Geng X, et al. Pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature. 2014;505:509-514.
Dotish G, Greene WC. Dissecting how CD4 T cells are lost during HIV infection. Cell Host Microbe. 2016;19:280-291.
Eckard AR, Rosebush JC, Lee ST, et al. Increased immune activation and exhaustion in HIV-infected youth. Pediatr Infect Dis J. 2016;35:e370-e377.
European AIDS Clinical Society. Guidelines Version 10.1 October 2020. https://www.eacsociety.org/media/guidelines-10.1_30032021_1.pdf. Accessed August 19, 2021.
Emu B, Fessel J, Schrader S, et al. Phase 3 study of ibalizumab for multidrug-resistant HIV-1. N Engl J Med. 2018;379:645-654.
Ferraz, R., Cunha, C.F., Pimentel, MIF, et al. CD3⁺CD4^negCD8^neg (double negative) T lymphocytes and NKT cells as the main cytotoxic-related-CD107a⁺ cells in lesions of cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis. Parasites Vectors. 2017;10:219.
Février M, Dorgham K, Rebollo A. CD4+ T cell depletion in human immunodeficiency virus (HIV) infection: role of apoptosis. Viruses. 2011 May;3:586-612.
Fülöp T, Herbein G, Cossarizza A, et al. Cellular senescence, immunosenescence and HIV. Interdiscip Top Gerontol Geriatr. 2017;42:28-46.
Galloway NL, Doitsh G, Monroe KM, et al. Cell-to-cell transmission of HIV-1 Is required to trigger pyroptotic death of lymphoid-tissue-derived CD4 T cells. Cell Rep. 2015;12:1555-1563.
Goetz C, Hammerbeck C, Bonnevier J. Flow Cytometry Basics for the Non-Expert. Minneapolis, MN: Springer; 2018.
Gonzalo-Gil E, Ikediobi U, Sutton RE. Mechanisma of virologic control and clinical characteristics of HIV+ Elite/Viremic controllers. Yale J Biol Med. 2017;90:245-259.
Greub G, Ledergerber B, Battegay M, et al. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet. 2000;356:1800.
Guadalupe M, Reay E, Sankaran S, et al. Severe CD4⁺ T-Cell Depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol. 2003;77:11708-11717.
Guenzel CA, Hérate C, Benichou S. HIV-1 Vpr-a still "enigmatic multitasker". Front Microbiol. 2014;5:127.
Hall BM. T Cells: soldiers and spies--the surveillance and control of effector T cells by regulatory T cells. Clin J Am Soc Nephrol. 2015;10:2050-2064.
Hughes MD, Stein DS, Gundacker HM, et al. Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: implications for patient monitoring. J Infect Dis. 1994;169:28-36.
Ho DD, Neumann AU, Perelson AS, et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 1995;373:123-126.
Iyasere C, Tilton JC, Johnson AJ, et al. Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2. J Virol. 2003;77:10900-10909.
James KD, Jenkinson WE, Anderson G. T-cell egress from the thymus: should I stay or should I go? J Leukoc Biol. 2018;104:275-284.
Khoo AL, Koenen HJ, Chai LY, et al. Seasonal variation in vitamin D₃ levels is paralleled by changes in the peripheral blood human T cell compartment. PLoS One. 2012;7:e29250.
Kim Y, Anderson JL, Lewin SR. Getting the "kill" into "shock and kill": strategies to eliminate latent HIV. Cell Host Microbe. 2018;23:14-26.
Kumar BV, Connors TJ, Farber DL. Human T cell development, localization, and function throughout life. Immunity. 2018;48:202-213.
Lataillade M, Lalezari JP, Kozal M, et al. Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE study. Lancet HIV. 2020;7:e740-e751.
Le Moing V, Thiébaut R, Chêne G, et al. Predictors of long-term increase in CD4(+) cell counts in human immunodeficiency virus-infected patients receiving a protease inhibitor-containing antiretroviral regimen. J Infect Dis. 2002;185:471-480.
Levast D, Barblu L, Coutu M, et al. HIV-1 gp120 envelope glycoprotein determinants for cytokine burst in human monocytes PLoS ONE. 2017;12:e0174550
Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department of Health and Human Services. Available at http://www.aidsinfo.nih.gov/ContentFiles/ AdultandAdolescentGL.pdf. Accessed August 19, 2021.
Pantaleo G, Graziosi C, Fauci AS. The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med. 1993;328:327-335.
Pol S, Artru P, Thépot V, et al. Improvement of the CD4 cell count after alcohol withdrawal in HIV-positive alcoholic patients. AIDS. 1996;10:1293-1294.
Maartens G, Boulle A. CD4 T-cell responses to combination antiretroviral therapy. Lancet. 2007;370:366-368.
Murphy K, et al. Janeway’s Immunobiology. 9th ed. New York, NY: Garland Science, Taylor & Francis Group; 2017:295-344.
Nakanjako D, Ssewanyana I, Mayanja-Kizza H, et al. High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort. BMC Infect Dis. 2011;11:43.
Nardacci R, Perfettini JL, Grieco L, et al. Syncytial apoptosis signaling network induced by the HIV-1 envelope glycoprotein complex: an overview. Cell Death Dis. 2015;6:e1846.
Scheller C, Jassoy C. Syncytium formation amplifies apoptotic signals: a new view on apoptosis in HIV infection in vitro. Virology. 2001;282:48-55.
Sharifi HJ, Furuya AM, de Noronha CM. The role of HIV-1 Vpr in promoting the infection of nondividing cells and in cell cycle arrest. Curr Opin HIV AIDS. 2012;7:187-194.
Stein DS, Korvick JA, Vermund SH. CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review. J Infect Dis. 1992;165:352-363.
Vandormael A, Rego F, Danaviah S. CD4+ T-cell count may not be a useful strategy to monitor antiretroviral therapy response in HTLV-1/HIV co-infected patients. Curr HIV Res. 2017;15:225-231.
van Praag RM, Prins JM, Roos MT, et al. OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletion. J Clin Immunol. 2001;21:218-26.
van Welzen BJ, de Vries TI, Arends JE, et al. The use of corticosteroids does not influence CD4+ lymphocyte recovery in HIV-infected patients with advanced immunodeficiency. AIDS Care. 2019. doi:10.1080/09540121.2019.1623376 [Epub ahead of print].
Vidya Vijayan KK, Karthigeyan KP, Tripathi SP, et al. Pathophysiology of CD4+ T-Cell depletion in HIV-1 and HIV-2 infections. Front Immunol. 2017;8:580.
Watanabe M, Iwatani Y, Hidaka Y, et al. Changes in soluble CD4 and CD8 proteins in healthy pregnant and postpartum women. Am J Reprod Immunol. 1996;36:220-227.
WHO. Laboratory guidelines for enumerating CD4 T lymphocytes in the context of HIV/AIDS (revised version 2009).https://apps.who.int/iris/handle/10665/205403. Accessed August 19, 2021.
Wilen CB, Tilton JC, Doms RW. HIV: cell binding and entry. Cold Spring Harb Perspect Med. 2012;2:pii:a006866.
Zambetti EF, Haramati LB, Jenny-Avital ER, et al. Detection and significance of splenomegaly on chest radiographs of HIV-infected outpatients. Clin Radiol. 1999;54:34-37.
Zonios D, Sheikh V, Sereti I. Idiopathic CD4 lymphocytopenia: a case of missing, wandering or ineffective T cells. Arthritis Res Ther. 2012;14:222.

CPD

CD4: Immunological Drivers of Depletion, Recovery, and Non-Response in HIV Infection

Authors: Richard Sutton, MD, PhD
CPD Released: 2/20/2020; Reviewed and Renewed: 8/31/2021
THIS ACTIVITY HAS EXPIRED FOR CREDIT
Valid for credit through: 8/31/2022

Target Audience and Goal Statement

This educational activity is intended for an international audience of non-US ID/HIV specialists, primary care physicians, and clinical immunologists.

The goal of this activity is to improve knowledge of the role of cluster of differentiation (CD) 4+ T cells in human immunodeficiency virus (HIV) pathogenesis and implications for HIV therapy.

Upon completion of this activity, participants will:

Have increased knowledge regarding the
- Role of CD4+ T cells in HIV pathogenesis
- Immunological mechanisms associated with CD4+ T cell depletion and recovery
- Clinical predictors and patient-associated factors of inefficient CD4+ T-cell gain during treatment

Disclosures

WebMD Global requires each individual who is in a position to control the content of one of its educational activities to disclose any relevant financial relationships occurring within the past 12 months that could create a conflict of interest.

Faculty

Richard Sutton, MD, PhD

Professor of Medicine
Yale School of Medicine
New Haven, Connecticut, United States

Disclosures

Disclosure: Richard Sutton, MD, PhD, has disclosed the following relevant financial relationships:
Received grants for clinical research from: ViiV Healthcare

Editor

Shanthi Voorn, PhD

Medical Education Director, WebMD Global, LLC

Disclosures

Disclosure: Shanthi Voorn, PhD, has disclosed no relevant financial relationships.

Content Reviewer

Esther Nyarko, PharmD

Associate Director, Accreditation and Compliance

Disclosures

Disclosure: Esther Nyarko, PharmD, has disclosed no relevant financial relationships.

Accreditation Statements

For Physicians

The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.50 continuing professional development credits (CPD).

Contact WebMD Global

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information about your eligibility to claim credit, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online during the credit eligibility period that is noted on the title page.

Follow these steps to claim a credit certificate for completing this activity:

Read the information provided on the title page regarding the target audience, learning objectives, and author disclosures, read and study the activity content and then complete the post-test questions. If you earn a passing score on the post-test and we have determined based on your registration profile that you may be eligible to claim CPD credit for completing this activity, we will issue you a CPD credit certificate.
Once your CPD credit certificate has been issued, you may view and print the certificate from your CME/CE Tracker. CPD credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of the Medscape Education homepage.

We encourage you to complete an Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

From Medscape Education

CPD

CD4: Immunological Drivers of Depletion, Recovery, and Non-Response in HIV Infection

Authors: Richard Sutton, MD, PhDFaculty and Disclosures

THIS ACTIVITY HAS EXPIRED FOR CREDIT

CPD Released: 2/20/2020; Reviewed and Renewed: 8/31/2021

Valid for credit through: 8/31/2022

processing....

A Powerpoint version of the slides from this presentation
is available for use as a professional resource from Medscape Education.

Download Now

CPD Information

Activity Transcript

Print
Like Tweet

Disclaimer

The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred. The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been authorized by the European Medicines Agency for use in Europe, off-label uses of authorized products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.

References

Faculty and Disclosures

Faculty

Richard Sutton, MD, PhD

Editor

Shanthi Voorn, PhD

Content Reviewer

Esther Nyarko, PharmD

CPD

CD4: Immunological Drivers of Depletion, Recovery, and Non-Response in HIV Infection

Target Audience and Goal Statement

Disclosures

Faculty

Richard Sutton, MD, PhD

Editor

Shanthi Voorn, PhD

Content Reviewer

Esther Nyarko, PharmD

Accreditation Statements

For Physicians

Instructions for Participation and Credit

CD4: Immunological Drivers of Depletion, Recovery, and Non-Response in HIV Infection